Advances in anticholinergic therapy delivery systems.
Davila
G Willy
GW
D000279:Administration, Cutaneous; D000283:Administration, Intravesical; D000284:Administration, Oral; D000285:Administration, Rectal; D018680:Cholinergic Antagonists / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D003692:Delayed-Action Preparations; D016503:Drug Delivery Systems; D006801:Humans; D008333:Mandelic Acids / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D010349:Patient Compliance; D010353:Patient Education as Topic; D013488:Suppositories; D014549:Urinary Incontinence / Q000188:drug therapy* / Q000503:physiopathology
D018680:Cholinergic Antagonists; D003692:Delayed-Action Preparations; D008333:Mandelic Acids; D013488:Suppositories; C005419:oxybutynin